Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2008 | ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation | Yang J.-Y.; Zong C.S.; Xia W.; Yamaguchi H.; Ding Q.; Xie X.; Lang J.-Y.; Lai C.-C.; Chang C.-J.; Huang W.-C.; Huang H.; Kuo H.-P.; Lee D.-F.; Li L.-Y.; HUANG-CHUN LIEN ; Cheng X.; KING-JEN CHANG ; Hsiao C.-D.; Tsai F.-J.; Tsai C.-H.; Sahin A.A.; Muller W.J.; Mills G.B.; Yu D.; Hortobagyi G.N.; Hung M.-C. | Nature Cell Biology | 556 | 521 | |
2018 | The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer | Antony J.; Zanini E.; Kelly Z.; Tan T.Z.; Karali E.; Alomary M.; Jung Y.; Nixon K.; Cunnea P.; Fotopoulou C.; Paterson A.; Roy-Nawathe S.; Mills G.B.; RUBY YUN-JU HUANG ; Thiery J.P.; Gabra H.; Recchi C. | EMBO Reports | 26 | 29 |